Ariotti, Sara

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2018 | 2017 | 2016


Ariotti, Sara; Ortega-Paz, Luis; van Leeuwen, Maarten; Brugaletta, Salvatore; Leonardi, Sergio; Akkerhuis, K Martijn; Rimoldi, Stefano F; Janssens, Gladys; Gianni, Umberto; van den Berge, Jan C; Karagiannis, Alexios; Windecker, Stephan; Valgimigli, Marco; Investigators, HI-TECH (2018). Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study. JACC. Cardiovascular Interventions, 11(16), pp. 1576-1586. Elsevier 10.1016/j.jcin.2018.04.022

Ortega-Paz, Luis; Brugaletta, Salvatore; Ariotti, Sara; Akkerhuis, K Martijn; Karagiannis, Alexios; Windecker, Stephan; Valgimigli, Marco; Endotherlial function and other Circulating biomarkInvestigators, Hunting for the off-target properties of Ticagrelor on (2018). Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea. Circulation, 138(6), pp. 646-648. Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.118.034489

Pilgrim, Thomas; Lee, Joe K T; O’Sullivan, Crochan J; Stortecky, Stefan; Ariotti, Sara; Franzone, Anna; Lanz, Jonas; Heg, Dik; Asami, Masahiko; Praz, Fabien; Siontis, George C M; Vollenbroich, René; Räber, Lorenz; Valgimigli, Marco; Roost, Eva; Windecker, Stephan (2018). Early versus newer generation devices for transcatheter aortic valve implantation in routine clinical practice: a propensity score matched analysis. Open Heart, 5(1), e000695. B M J Group 10.1136/openhrt-2017-000695

Gargiulo, Giuseppe; Ariotti, Sara; Vranckx, Pascal; Leonardi, Sergio; Frigoli, Enrico; Ciociano, Nestor; Tumscitz, Carlo; Tomassini, Francesco; Calabrò, Paolo; Garducci, Stefano; Crimi, Gabriele; Andò, Giuseppe; Ferrario, Maurizio; Limbruno, Ugo; Cortese, Bernardo; Sganzerla, Paolo; Lupi, Alessandro; Russo, Filippo; Garbo, Roberto; Ausiello, Arturo; ... (2018). Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial. JACC. Cardiovascular Interventions, 11(1), pp. 36-50. Elsevier 10.1016/j.jcin.2017.09.014


Gargiulo, Giuseppe; Santucci, Andrea; Piccolo, Raffaele; Franzone, Anna; Ariotti, Sara; Baldo, Andrea; Esposito, Giovanni; Moschovitis, Aris; Windecker, Stephan; Valgimigli, Marco (2017). Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial. Catheterization and cardiovascular interventions, 90(4), E73-E84. Wiley-Blackwell 10.1002/ccd.26921

Ariotti, Sara; van Leeuwen, Maarten; Brugaletta, Salvatore; Leonardi, Sergio; Akkerhuis, Kristiaan Martijn; Rexhaj, Emrush; Janssens, Gladys; Ortega-Paz, Luis; Rizzotti, Diego; van den Berge, Jan C; Heg, Dierik Hans; Francolini, Gloria; Windecker, Stephan; Valgimigli, Marco (2017). Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trial. American Heart Journal, 189, pp. 128-136. Elsevier 10.1016/j.ahj.2017.03.017

Piccolo, Raffaele; Magnani, Giulia; Ariotti, Sara; Gargiulo, Giuseppe; Marino, Marcello; Santucci, Andrea; Franzone, Anna; Tebaldi, Matteo; Heg, Dik; Windecker, Stephan; Valgimigli, Marco (2017). Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial. EuroIntervention, 13(1), pp. 78-86. Europa Digital & Publishing 10.4244/EIJ-D-16-00497


Franzone, Anna; Piccolo, Raffaele; Gargiulo, Giuseppe; Ariotti, Sara; Marino, Marcello; Santucci, Andrea; Baldo, Andrea; Magnani, Giulia; Moschovitis, Aris; Windecker, Stephan; Valgimigli, Marco (2016). Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial. JAMA cardiology, 1(7), pp. 795-803. American Medical Association 10.1001/jamacardio.2016.2811

Gargiulo, Giuseppe; Ariotti, Sara; Santucci, Andrea; Piccolo, Raffaele; Baldo, Andrea; Franzone, Anna; Magnani, Giulia; Marino, Marcello; Esposito, Giovanni; Windecker, Stephan; Valgimigli, Marco (2016). Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial. JACC. Cardiovascular Interventions, 9(17), pp. 1780-1789. Elsevier 10.1016/j.jcin.2016.05.046

Adamo, Marianna; Ariotti, Sara; Costa, Francesco; Curello, Salvatore; Moschovitis, Aris; de Vries, Ton; White, Harvey D; Windecker, Stephan; Valgimigli, Marco (2016). Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial. JACC. Cardiovascular Interventions, 9(16), pp. 1667-1676. Elsevier 10.1016/j.jcin.2016.05.031

Crimi, Gabriele; Leonardi, Sergio; Costa, Francesco; Adamo, Marianna; Ariotti, Sara; Valgimigli, Marco (2016). Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial. International journal of cardiology, 212, pp. 110-117. Elsevier 10.1016/j.ijcard.2016.03.033

Santucci, Andrea; Gargiulo, Giuseppe; Ariotti, Sara; Marino, Marcello; Magnani, Giulia; Baldo, Andrea; Piccolo, Raffaele; Franzone, Anna; Valgimigli, Marco (2016). Radial versus femoral approach in STEMI: what do we know so far? Minerva cardioangiologica, 64(3), pp. 219-237. Minerva Medica

Gargiulo, Giuseppe; Costa, Francesco; Ariotti, Sara; Biscaglia, Simone; Campo, Gianluca; Esposito, Giovanni; Leonardi, Sergio; Vranckx, Pascal; Windecker, Stephan; Valgimigli, Marco (2016). Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. American Heart Journal, 174, pp. 95-102. Elsevier 10.1016/j.ahj.2016.01.015

Ariotti, Sara; Adamo, Marianna; Costa, Francesco; Patialiakas, Athanasios; Briguori, Carlo; Thury, Attila; Colangelo, Salvatore; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; de Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique Mesquita; Ferlini, Marco; Vranckx, Pascal; ... (2016). Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial. JACC. Cardiovascular Interventions, 9(5), pp. 426-436. Elsevier 10.1016/j.jcin.2015.11.015

Costa, Francesco; Adamo, Marianna; Ariotti, Sara; Ferrante, Giuseppe; Navarese, Eliano Pio; Leonardi, Sergio; Garcia-Garcia, Hector; Vranckx, Pascal; Valgimigli, Marco (2016). Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration. EuroIntervention, 11(11), e1222-e1230. Europa Digital & Publishing 10.4244/EIJY15M08_04

Provide Feedback